1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsScreening & Support Grants is sponsored by Breast Cancer Alliance. Funds institutions providing screening and diagnostic breast cancer services (mammograms, ultrasounds) for underserved and underinsured populations in Connecticut and/or Westchester County, New York. Focuses on increasing access to early detection for women.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Screening & Support Grants | Empower Early Detection Today — breastcanceralliance. org Screening and Diagnostics Applications will be available October 2026 The mission of Breast Cancer Alliance is to improve survival rates and quality of life for those impacted by breast cancer through better prevention, early detection, treatment and cure.
To achieve these goals, Breast Cancer Alliance funds institutions that provide screening and diagnostic breast cancer services for underserved and underinsured populations through: screening, diagnostic mammograms, and ultrasounds. The programs must be located in Connecticut and/or in Westchester County, New York . The term of the Screening and Diagnostics Grant is one calendar year beginning April 1, 2027.
Breast Cancer Alliance does not fund MRIs, patient counseling, patient navigation, office supplies, medical supplies, financial aid (i.e. gas bills, transportation, rent, overhead, grocery gift certificates, fringe benefits, etc.) printing costs, travel costs, marketing costs, recruitment costs or training programs. The 2027 application is available here .
( link coming soon ) Regular applications are due by on or before midnight on December 13, 2026 . Applications received after the deadline will not be considered. Funding is determined on an annual basis, per each grant cycle.
Prior gift allocations do not guarantee future grants. The Grants Committee of Breast Cancer Alliance reviews and evaluates each grant proposal. The results of the Grants Committee’s evaluations and subsequent recommendations are presented to the BCA Board for approval.
Applicants are notified by March 2027 of the decision regarding their proposals. Grant recipients must submit the required midterm report by October 1, 2027 and a final report by April 30, 2028. Any publicity associated with the program must acknowledge Breast Cancer Alliance as a supporter.
The 2027 midterm and final report templates will available on Smarter Select. A virtual site visit by Screening and Diagnostics committee members is a requirement of this grant.
According to the current listing, eligibility includes: Nonprofit organizations and institutions operating screening/diagnostic programs in the specified geographic areas. Confirm the full requirements in the official notice before applying.
Applications for Screening & Support Grants are due December 13, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Screening & Support Grants is funded by Breast Cancer Alliance. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
CDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read article